Aclaris Therapeutics saw the highest growth of 1.99% in patent filings in May and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Aclaris Therapeutics’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Aclaris Therapeutics has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings with nearly 75% of filings. The United States(US), World Intellectual Property Organization(WIPO), and South Korea(KR) patent Office are among the top ten patent offices where Aclaris Therapeutics is filings its patents. Among the top granted patent authorities, Aclaris Therapeutics has 100% of its grants in South Korea(KR).
Roche and Johnson & Johnson could be the strongest competitors for Aclaris Therapeutics
Patents related to rare diseases lead Aclaris Therapeutics's portfolio
Aclaris Therapeutics has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Rheumatoid arthritis related patents lead Aclaris Therapeutics portfolio followed by lymphoma, and psoriasis
Aclaris Therapeutics has highest number of patents in rheumatoid arthritis followed by lymphoma, psoriasis, ileitis, and alopecia areata. For rheumatoid arthritis, nearly 1% of patents were filed and 17% of patents were granted in Q2 2024.
For comprehensive analysis of Aclaris Therapeutics's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
